ICU Medical, Inc. (ICUI) research: valuation against peers, fundamentals over time, risk and news coverage
ICUI
ICU Medical, Inc.No data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- SPECIAL REPORTNEUTRALQ2 Earnings Wave Splits Market: Medtech and Fintech Beat as Consumer Names Retrench
Natera oncology volumes rose 57.2%, iRhythm revenue climbed 20% with raised guidance, ICU Medical posted record Infusion Systems revenue on 12% organic growth, and Nu Holdings cleared $1B in quarterly profit. Offsetting that, Post's pet food volumes fell 7.8%, i3 Verticals cut guidance, and Dragonfly Energy is pivoting away from a soft RV end market.
- BREAKING STORYBEARISHInsider Selling Cluster Spans Industrials, MedTech and Mobility in Single Session
A notably broad cluster of insider sales crossed the wire covering ICU Medical (COO $1.63m, director $68,978), AZZ (president and COO $647,981), CSW Industrials ($249,811), Lyft (director $241,740), Beta Technologies (CEO $1.15m) and Miami International Holdings ($137,370). While many transactions were pre-scheduled under Rule 10b5-1 plans, the concentration across unrelated sectors in a single session is a signal worth monitoring on valuation grounds.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.